DENVER, July 30, 2019 /PRNewswire/ -- DaVita Kidney Care,
a leading provider of kidney care services in the United States, announced today that growth
of its peritoneal dialysis and home hemodialysis programs is four
times the growth rate of in-center treatment options.* This comes
on the heels of DaVita's success with its new Home Remote
Monitoring program that allows patients to consistently share
clinical information with their care team. The company's home
growth rate is also a testament to the engagement and support for
appropriate home dialysis among its physician leaders.
"This is a transformational time in U.S. health care—one where
the consideration and acceptance of home-based treatments is higher
than I've seen in the 30 years I've been part of the medical
community," said Dr. Martin
Schreiber, chief medical officer for Home Dialysis at DaVita
Kidney Care. "Patient choice has always been at the center of
everything we do, and greater consideration for home dialysis is
now being met with greater physician engagement, intuitive
education and support programs to enable more patients to choose
home treatments when appropriate."
DaVita is the largest provider of home dialysis therapy in the
U.S. and continues to invest in patient-centered solutions,
including technology and education, to improve patient experience
and outcomes while its home dialysis program has grown.
Home Dialysis Connect™, for example, is a suite of
technology innovations designed to improve the care experience and
outcomes for patients on home dialysis. In 2018 alone, more than
13,000 patients have been impacted. Home Dialysis Connect features
the following components:
- Home Remote Monitoring (HRM) uses Bluetooth-enabled
devices to transmit vital patient data, which is risk-stratified
and helps clinicians stay on top of potential outcome-impacting
events for patients. Since its inception, 13,000 DaVita home
dialysis patients have transmitted over 2 million data points to
their care team, helping their team better manage their care and
keep them on their home modality of choice.
- Telehealth platform allows patients to schedule and
participate in virtual appointments with their care team, instead
of traveling to a center.
- DaVita Care Connect is a mobile patient application that
supports multi-way video visits, customized education, reminders,
secure texting and image sharing—allowing consistent access to
their care team.
- Artificial Intelligence (AI)/Predictive Analytics.
DaVita uses AI and predictive analytics built with the largest home
dialysis data set in the U.S. and consisting of millions of
clinical notes to help identify patients who are at higher risk of
hospitalization events, which often lead patients to leave
peritoneal dialysis therapy. Predictions are built into center work
flows, allowing nurses and care teams to intervene when necessary
to help avoid hospitalizations and keep patients on their home
modality of choice.
- Health Management Navigator is a series of online
interactive courses designed to train nurses to become
comprehensive health managers for patients with diabetes,
cardiovascular disease and hypertension. This helps DaVita care
teams deliver the right interventions at the right time based on
each patient's unique clinical needs while they treat at home.
"DaVita is working to transform care to give any eligible
patient that wants to pursue a home treatment option the resources
to succeed," said Dr. Schreiber. "For 20 years and counting, we've
been committed to creating home innovation to allow us to grow our
programs as more patients choose home dialysis as their treatment
option."
* Based on comparative growth rates for twelve month period
ended June 2019.
Forward Looking Statements
This release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995 ("PSLRA").
All such statements in this release, other than statements of
historical fact, are forward-looking statements and as such are
intended to be covered by the safe harbor for "forward-looking
statements" provided by the PSLRA. Without limiting the foregoing,
statements including the words "expect," "intend," "will," "plan,"
"anticipate," "believe," "we are confident that," "forecast,"
"guidance," "outlook," "goals," and similar expressions are
intended to identify forward-looking statements.
These forward-looking statements could include but are not
limited to statements related to our expectations generally
regarding our investment decisions, market positioning, future
business performance and financial results. Our actual results
and other events could differ materially from any forward-looking
statements due to numerous factors that involve substantial known
and unknown risks and uncertainties. These risks and uncertainties
include, among other things, those set forth in our Form 8-K
furnished to the SEC on February 13,
2019, the risk factors set forth in our most recent
quarterly report on Form 10-Q, and the other risks and
uncertainties discussed in any of our subsequent filings with the
SEC from time to time, all of which are expressly incorporated
herein by reference.
The forward-looking statements should be considered in light of
these risks and uncertainties. All forward-looking statements in
this release are based solely on information available to us on the
date of this release. We undertake no obligation to publicly update
or revise any of our forward-looking statements, whether as a
result of changed circumstances, new information, future events or
otherwise.
About DaVita Inc.
DaVita (NYSE: DVA) is a Fortune 500® health care provider
focused on transforming care delivery to improve quality of life
for patients around the globe. The company is the largest provider
of kidney care services in the U.S. and has been a leader in
clinical quality and innovation for 20 years. Through DaVita Kidney
Care, the company treats patients with chronic kidney failure and
end stage renal disease. DaVita is committed to bold,
patient-centric care models, implementing the latest technologies
and moving toward integrated care offerings for all. As of
March 31, 2019, DaVita serves 203,000
patients at 2,689 outpatient dialysis centers in the United States. DaVita also operates 243
outpatient dialysis centers in nine countries across the world.
DaVita has reduced hospitalizations, improved mortality, and worked
collaboratively to propel the kidney care industry to adopt an
equitable and high-quality standard of care for all patients,
everywhere. To learn more about how DaVita is leading the health
care evolution, please, visit DaVita.com/About.
Contact Information
Media:
Halie Peddle
Halie.Peddle@DaVita.com
(303) 550-6349
View original content to download
multimedia:http://www.prnewswire.com/news-releases/innovation-in-home-care-delivery-improves-the-quality-of-life-for-more-kidney-patients-300893308.html
SOURCE DaVita